Comparison of the protective efficacy of bacille Calmette-Gueérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis

Clinical Infectious Diseases

Volumn 30, Issue , 2000, Pages S299-S301

  Williams, Ann ^a   Davies, Angela ^a   Marsh, Philip D ^a   Chambers, Mark A ^b   Hewinson, R Glyn ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; BCG VACCINATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GUINEA PIG; LUNG INJURY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SPLEEN;

ANIMALS; BCG VACCINE; COLONY COUNT, MICROBIAL; FEMALE; GUINEA PIGS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0034465230     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313878     Document Type: Article

References (10)

1. The BCG experience: Implications for future vaccines against tuberculosis
2. Modern vaccines. Mycobacterial diseases
3. Relationship between bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis
4. The epidemiology of Mycohacterium bovis infections in animals and man: A review
5. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. boris
6. Physical mapping of Mycobacterium bovis BCG Pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis
7. Prospects for new interventions in the treatment and prevention of mycobacterial disease
8. Genetic systems for mycobacteria
9. A mobile form of the Henderson apparatus